John Koerner - Concepedia

Author

John Koerner

United States Food and Drug Administration

Also Known As

J KOERNER, J. E. KOERNER, J. E. Koerner, J.E. Koerner, John E. Koerner, John Koerner

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Health and Environmental Sciences Institute Center for Drug Evaluation and Research Amgen (United States)Eli Lilly (United States)

About

John Koerner is an author at United States Food and Drug Administration specializing in medicine, cardiovascular disease, and anesthesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	199
2	Engineering	1	1	44
3	Health Sciences	1	1	16
4	Public Health	1	1	74
5	Biomedical Engineering	1	1	16

John Koerner

Publications

637

Citations

H-Index

Page 1

	Year	Citations
Comparative Evaluation of HERG Currents and QT Intervals following Challenge with Suspected Torsadogenic and Nontorsadogenic Drugs Alexander N. Katchman, John Koerner, Toshimasa Tosaka, Journal of Pharmacology and Experimental Therapeutics	2006	136
Cardiovascular Function in Nonclinical Drug Safety Assessment R. Dustan Sarazan, Scott W. Mittelstadt, Brian D. Guth, International Journal of Toxicology Drug SafetyCardiovascular ToxicityHypertensionHeart FailureCardiovascular Translational Research	2011	74
Can non‐clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium Eun‐Jung Park, Gary A. Gintant, Daoqin Bi, British Journal of Pharmacology	2017	65
Protection Against Postischemic Myocardial Dysfunction in Anesthetized Rabbits with Scavengers of Oxygen-Derived Free Radicals John Koerner, Barbara A. Anderson, Richard C. Dage Journal of Cardiovascular Pharmacology	1991	54
The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium Brian D. Guth, Alan Y. Chiang, Jennifer Doyle, Journal of Pharmacological and Toxicological Methods	2015	54
A HESI consortium approach to assess the human predictive value of non-clinical repolarization assays Elena S. Trepakova, John Koerner, Syril Pettit, Journal of Pharmacological and Toxicological Methods Human Predictive ValueEngineeringClinical TranslationTranslational BioinformaticsHesi Consortium Approach	2009	44
SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats—Histopathologic, Electron Microscopic, and Immunohistochemical Studies Jun Zhang, Eugene H. Herman, Alan Knapton, Toxicologic Pathology F 95654-InducedCardiovascular PharmacologyCell DeathAcute Cardiovascular ToxicityPharmacotherapy	2002	40
Proarrhythmia liability assessment and the comprehensive in vitro Proarrhythmia Assay (CiPA): An industry survey on current practice Simon Authier, Michael K. Pugsley, John Koerner, Journal of Pharmacological and Toxicological Methods	2017	34
Coronary blood flow in physically trained rats Kerry L. Spear, John Koerner, Ronald L. Terjung Cardiovascular Research	1978	27
A public–private consortium advances cardiac safety evaluation: Achievements of the HESI Cardiac Safety Technical Committee Jennifer Pierson, Brian R. Berridge, Marjory B. Brooks, Journal of Pharmacological and Toxicological Methods	2013	27

Page 1